Literature DB >> 17876102

Induction and regulation of inflammatory bowel disease in immunodeficient mice by distinct CD4+ T-cell subsets.

Kevin J Maloy1.   

Abstract

Although the etiology of human inflammatory bowel disease (IBD) has not yet been completely defined, the current prevailing hypothesis is that it is caused by aberrant immune responses, or loss of tolerance, toward components of the intestinal bacterial microflora. During the past decade, several animal models of IBD have been developed that reproduce many features of the human disease. This article will outline one of the best characterized murine IBD models, the "T-cell transfer model" where colitis rapidly develops following adoptive transfer of naive CD4+CD45RB high T cells into immunodeficient scid or RAG-/- mice. This model has also been instrumental in characterizing the potent suppressive activities of CD4+CD25+ regulatory T cells that prevent the development of IBD when cotransferred with the naive CD4+ T cells. The T cell transfer model of IBD is reproducible and easily manipulated and therefore provides an excellent system for the study of immunopathology and immune regulation in the intestine.

Entities:  

Mesh:

Year:  2007        PMID: 17876102     DOI: 10.1007/978-1-59745-395-0_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection.

Authors:  Ursula Hofer; Roberto F Speck
Journal:  Semin Immunopathol       Date:  2009-05-30       Impact factor: 9.623

2.  Wiskott-Aldrich syndrome protein deficiency in innate immune cells leads to mucosal immune dysregulation and colitis in mice.

Authors:  Deanna D Nguyen; Marc-Andre Wurbel; Jeremy A Goettel; Michelle A Eston; Osub S Ahmed; Romela Marin; Elisa K Boden; Eduardo J Villablanca; Helena Paidassi; Vineet Ahuja; Hans-Christian Reinecker; Edda Fiebiger; Adam Lacy-Hulbert; Bruce H Horwitz; J Rodrigo Mora; Scott B Snapper
Journal:  Gastroenterology       Date:  2012-06-15       Impact factor: 22.682

3.  TRIM28 prevents autoinflammatory T cell development in vivo.

Authors:  Shunsuke Chikuma; Naomasa Suita; Il-Mi Okazaki; Shiro Shibayama; Tasuku Honjo
Journal:  Nat Immunol       Date:  2012-04-29       Impact factor: 25.606

4.  Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis.

Authors:  Hwei-Fang Tsai; Chien-Sheng Wu; Yi-Lin Chen; Hsiu-Jung Liao; I-Tsu Chyuan; Ping-Ning Hsu
Journal:  J Mol Med (Berl)       Date:  2015-12-02       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.